About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Evidence-based Analysis of Low-dose CT in Management of COPD

NCT02599883·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Azienda Ospedaliero-Universitaria di Parma

Age

40–90

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

COPD diagnosis according to ATS/ERS criteria (post-bronchodilator FEV1 to FVC ratio \< 0.7);
clinical stability, namely no acute exacerbation in the previous 4 weeks;
clinical indication for low-dose computed tomography (LDCT) to investigate bronchiectasis, interstitial lung disease, or pulmonary hypertension.

You may not be if

pregnancy;
patients with congenital or acquired immune deficit;
patients with lung transplantation;
patients under oxygen therapy;
patients with diagnosis of asthma or other clinically relevant pulmonary disease other than COPD.

The record

StatusCompleted

PhaseNo phase

Taking part195

StartedSep 2012

UpdatedNov 9, 2015

Conditions

Chronic Obstructive Pulmonary Disease

Clareo Health | Evidence-based Analysis of Low-dose CT in Management of COPD